ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin

LIU Xiao-qing; GOU Lan-ying

doi:10.3969/j.issn.1671-5144.2013.04.007

LIU Xiao-qing, GOU Lan-ying. ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin[J]. Journal of Evidence-Based Medicine, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007

Citation:

LIU Xiao-qing, GOU Lan-ying. ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin[J]. Journal of Evidence-Based Medicine, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007

Citation:

LIU Xiao-qing, GOU Lan-ying. ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin[J]. Journal of Evidence-Based Medicine, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007

ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin

Graphical Abstract

Abstract

FullText(HTML)

References (9)

ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin

Catalog

Export File

Citation

Format

Content